LAMEA Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of Administration (Injectable and Oral & Others), By Application, By Drug Class, By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Gastrointestinal Therapeutics Market, by Type
1.4.2 LAMEA Gastrointestinal Therapeutics Market, by Distribution Channel
1.4.3 LAMEA Gastrointestinal Therapeutics Market, by Route of Administration
1.4.4 LAMEA Gastrointestinal Therapeutics Market, by Application
1.4.5 LAMEA Gastrointestinal Therapeutics Market, by Drug Class
1.4.6 LAMEA Gastrointestinal Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Gastrointestinal Therapeutics Market

Chapter 4. LAMEA Gastrointestinal Therapeutics Market by Type
4.1 LAMEA Branded Market by Country
4.2 LAMEA Generics Market by Country

Chapter 5. LAMEA Gastrointestinal Therapeutics Market by Distribution Channel
5.1 LAMEA Retail Pharmacies Market by Country
5.2 LAMEA Hospital Pharmacies Market by Country
5.3 LAMEA Online Pharmacies Market by Country

Chapter 6. LAMEA Gastrointestinal Therapeutics Market by Route of Administration
6.1 LAMEA Injectable Market by Country
6.2 LAMEA Oral & Others Market by Country

Chapter 7. LAMEA Gastrointestinal Therapeutics Market by Application
7.1 LAMEA Crohn's Disease Market by Country
7.2 LAMEA Ulcerative Colitis Market by Country
7.3 LAMEA GERD Market by Country
7.4 LAMEA IBS Market by Country
7.5 LAMEA Others Market by Country

Chapter 8. LAMEA Gastrointestinal Therapeutics Market by Drug Class
8.1 LAMEA Biologics/Biosimilar Market by Country
8.2 LAMEA Anti-Diarrheal Market by Country
8.3 LAMEA Anti-Emetics Market by Country
8.4 LAMEA Digestive Enzymes Market by Country
8.5 LAMEA Aminosalicylates Market by Country
8.6 LAMEA Proton Pump Inhibitors Market by Country
8.7 LAMEA Laxatives & H2 Antagonists Market by Country
8.8 LAMEA Others Market by Country

Chapter 9. LAMEA Gastrointestinal Therapeutics Market by Country
9.1 Brazil Gastrointestinal Therapeutics Market
9.1.1 Brazil Gastrointestinal Therapeutics Market by Type
9.1.2 Brazil Gastrointestinal Therapeutics Market by Distribution Channel
9.1.3 Brazil Gastrointestinal Therapeutics Market by Route of Administration
9.1.4 Brazil Gastrointestinal Therapeutics Market by Application
9.1.5 Brazil Gastrointestinal Therapeutics Market by Drug Class
9.2 Argentina Gastrointestinal Therapeutics Market
9.2.1 Argentina Gastrointestinal Therapeutics Market by Type
9.2.2 Argentina Gastrointestinal Therapeutics Market by Distribution Channel
9.2.3 Argentina Gastrointestinal Therapeutics Market by Route of Administration
9.2.4 Argentina Gastrointestinal Therapeutics Market by Application
9.2.5 Argentina Gastrointestinal Therapeutics Market by Drug Class
9.3 UAE Gastrointestinal Therapeutics Market
9.3.1 UAE Gastrointestinal Therapeutics Market by Type
9.3.2 UAE Gastrointestinal Therapeutics Market by Distribution Channel
9.3.3 UAE Gastrointestinal Therapeutics Market by Route of Administration
9.3.4 UAE Gastrointestinal Therapeutics Market by Application
9.3.5 UAE Gastrointestinal Therapeutics Market by Drug Class
9.4 Saudi Arabia Gastrointestinal Therapeutics Market
9.4.1 Saudi Arabia Gastrointestinal Therapeutics Market by Type
9.4.2 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel
9.4.3 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration
9.4.4 Saudi Arabia Gastrointestinal Therapeutics Market by Application
9.4.5 Saudi Arabia Gastrointestinal Therapeutics Market by Drug Class
9.5 South Africa Gastrointestinal Therapeutics Market
9.5.1 South Africa Gastrointestinal Therapeutics Market by Type
9.5.2 South Africa Gastrointestinal Therapeutics Market by Distribution Channel
9.5.3 South Africa Gastrointestinal Therapeutics Market by Route of Administration
9.5.4 South Africa Gastrointestinal Therapeutics Market by Application
9.5.5 South Africa Gastrointestinal Therapeutics Market by Drug Class
9.6 Nigeria Gastrointestinal Therapeutics Market
9.6.1 Nigeria Gastrointestinal Therapeutics Market by Type
9.6.2 Nigeria Gastrointestinal Therapeutics Market by Distribution Channel
9.6.3 Nigeria Gastrointestinal Therapeutics Market by Route of Administration
9.6.4 Nigeria Gastrointestinal Therapeutics Market by Application
9.6.5 Nigeria Gastrointestinal Therapeutics Market by Drug Class
9.7 Rest of LAMEA Gastrointestinal Therapeutics Market
9.7.1 Rest of LAMEA Gastrointestinal Therapeutics Market by Type
9.7.2 Rest of LAMEA Gastrointestinal Therapeutics Market by Distribution Channel
9.7.3 Rest of LAMEA Gastrointestinal Therapeutics Market by Route of Administration
9.7.4 Rest of LAMEA Gastrointestinal Therapeutics Market by Application
9.7.5 Rest of LAMEA Gastrointestinal Therapeutics Market by Drug Class

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 AbbVie, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Approvals and Trials:
10.3 Takeda Pharmaceutical Company Limited
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisition and Mergers:
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.5 Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.6 Johnson & Johnson (Janssen Global Services, LLC)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental &Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 AstraZeneca PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.8 Bayer AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 Sun Pharmaceutical Industries Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.10. Cipla Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense